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CASE HISTORY 
A 48-year-old male patient had a surgical resection of a right testis seminoma. During preoperative 
imaging studies, a solitary nodule of the left adrenal gland was found. Since the suspected pre-
operative diagnosis was a nonfunctioning cortical adenoma, in the absence of hormonal hyper-
incretion effects, the adrenal lesion was removed six months after the testis surgery. 
 
WHAT IS YOUR DIAGNOSIS? 
 
Histopathologic diagnosis: Composite Adrenal Adenomatoid Tumor, Ganglioneuroma, 
Myelolipoma and Cortical Nodular Hyperplasia 
The adrenalectomy specimen consisted of a bilobated tumour measuring 4 cm in its maximum 
diameter with a pale grey and partly yellowish, smooth cut surface. There were a few cystic spaces 
of 0.5 to 1 cm, but neither hemorrhage nor necrosis were noted. A rim of cortical tissue at the 
periphery was found.  Microscopically, four different morphological patterns were found (Figure 
1). The first was a well circumscribed area, composed of interweaving fascicles of Schwann cells, 
with no immature element, in a myxoid stroma containing mature ganglion cells and scant adipose 
tissue (Figure 2A, B). The other three components were intermingled one into each other, and 
distinct from the former. Among them, anastomosing tubules and cleft-like spaces of variable size 
and shape were observed, some of which arranged in multiple microcysts and separated by 
fibrous stromal bundles. These structures were lined by  plump epithelioid or flattened cells 
resembling endothelial cells (Figure 3A, B). such cells merged in some areas with nests of cells 
having a prominent vacuolization and eccentrically placed nuclei conferring a signet ring cell 
appearance. The nuclei were otherwise uniform and round to oval, with no pleomorphism nor 
significant mitotic activity. In addition, there were scant islands of adipose and hematopoietic 
tissues resembling mature bone marrow (Figure 1B), with megakaryocytes, erythroid, myeloid and 
lymphoid cells, with no precursor myeloblasts.  The third component, accounting for 40% of the 
whole lesion, was composed by hyperplastic adrenocortical tissue lacking evident fibrous capsule 
(Figure 1C).  By immunohistochemistry, a peripheral neural sheat derivation was confirmed for the 
first lesion, being Melan A and Steroidogenic Factor 1 negative (Figure 2C) and S100 protein 
positive only (Figure 2D). Conversely, the microcystic and tubular structures covered by flattened 
cells displayed evidence of mesothelial differentiation, with a strong positivity for cytokeratin 
AE1/AE3, calretinin and WT1 (Figure 3C), in the absence of adrenocortical (Melan A, Steroidogenic 
Factor 1) and endothelial marker expression (CD31, CD34, ERG) (Figure 3D). Therefore, the 
morphological and immunophenotypical features of these lesions led to a diagnosis of a combined 
ganglioneuroma and adenomatoid tumor with foci of myelolipoma in an adrenal gland with 
nodular cortical hyperplasia.  
 
COMMENT 
To the best of our knowledge, both adenomatoid tumors and ganglioneuromas have been 
reported in association either with myelolipoma (1) (2) or adrenocortical adenoma (3) (4) or 
nodular cortical hyperplasia (5), but a quadruple combination of ganglioneuroma, adenomatoid 
tumor, myelolipoma and nodular hyperplasia in a single tumor of the adrenal gland has not been 
described in the literature, so far. The uniqueness of this case is emphasized by the fact that at 
least two of the tumor components (adenomatoid tumor and myelolipoma) arise from tissues that 
are presumably foreign to those of the adrenal gland. Adenomatoid tumors are benign neoplasms 
with mesothelial differentiation, which are usually found in the genital tract of both males 
(epididymis, testicular tunica, and spermatic cord) and females (uterus, fallopian tubes, and more 
rarely, ovary) (6). As the coelomic epithelium gives rise to both mesothelial lining and adrenal 
cortex, it can be easily understood why adrenal glands may host mesothelial-derived neoplasms 
such as adenomatoid tumors, generally thought to derive from mesothelial inclusions. In addition, 
the close embryologic relationship between adrenal gland and the mullerian tract can explain both 
heterotopic adrenal cortical tissue in the periovarian region and adenomatoid tumor in the 
adrenal gland (7). Among various hypotheses underlying the development of myelolipoma (bone 
marrow embolization, embryonic primitive mesenchymal cells, dysregulation of hematopoietic cell 
apoptosis), the most consistent is the differentiation of undifferentiated mesenchymal cells to 
myeloid and lipoid tissues activated by systemic stress from chronic illness, necrotic tissue or high-
energy trauma (8). Similarly to adenomatoid tumors, the presence of haematopoietic tissue in the 
adrenal gland can be explained embryonically because the adrenal cortex and bone marrow 
originate from the same mesenchymal tissues (9). This theory is supported by animal studies 
where myelolipomatous changes were seen after injecting necrotic tissues in rats (10). However, 
the relationship and pathogenetic links between the medulla and cortex and their tumors, and 
therefore whether both components grow independently or in an interrelated manner remains 
unresolved. The imaging characteristics of both adrenal ganglioneuroma and adenomatoid tumor 
are quite variable being some very similar to other adrenal tumors such as adrenocortical 
carcinoma and pheochromocytoma (11). Therefore, a definitive diagnosis can be obtained after 
surgery, only. In our case, the ganglioneuroma was a discrete tumor, while the adenomatoid 
tumor was intermingled with hyperplastic adrenocortical cells growing in a nodular fashion. 
Among the lesions encountered in this exceptional case, the most challenging for the pathologist 
is the adenomatoid tumor, as its lymphangiomatoid and microcystic-cavernous growth patterns 
could be interpreted as a vascular neoplasm, particularly a lymphangioma (12). However, the 
positivity for epithelial and mesothelial markers and the absence of vascular and lymphatic 
markers generally easily address to the correct differential diagnosis. In addition, the complex 
tubules with adenoid appearance and those with a packed-solid growth with vacuolated cells may 
simulate metastatic adenocarcinoma or signet ring cell carcinoma, but the lack of pleomorphism, 
mitotic figures, necrosis, and cellular atypia rules out the suspicion of malignancy (13).  
 
In conclusion, we reported an exceptionally rare benign adrenal lesion made of four components 
of different embryological derivation, which expands the potential repertoire of combined tumors 
occurring in the adrenal gland. 
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FIGURE LEGENDS. 
Figure 1. Representative areas of the four different morphological aspects found in the adrenal 
node: fascicles of spindle cells with minimal adipose tissue (A) and a rim of normal adrenal gland  
(top right); anastomosing tubules and multiple microcysts and separated by solid fibrous stroma 
(left) and islands of adipose and hematopoietic tissues resembling mature bone marrow (right) 
(B); hyperplastic adrenocortical tissue lacking evident fibrous capsule (C). (A-C: Hematoxylin & 
Eosin, original magnification 40X). 
 
Figure 2. Interweaving fascicles of Schwann cells, with no immature element, containing adipose 
tissue (A) and mature ganglion cells (B). Ganglion cells (left) were negative for Melan A (Figure 2C) 
and positive for S100 protein (Figure 2D) (A, B: Hematoxylin & Eosin, original magnification 200X; 
C, D: immunoperoxidase, original magnification 400X). 
 
Figure 3. Multiple microcysts and (A) with tubules and cleft-like spaces of variable size and shape 
(B). The structures are lined by plump epithelioid to flattened cells, occasionally having a 
prominent vacuolization conferring a signet ring cell appearance. These cells are positive for 
calretinin (C), but negative CD31 (D)  (A-B: Hematoxylin & Eosin, original magnification 200X; C-D: 
immunoperoxidase, original magnification 400X). 
 
 
 
 
 
 
